Amino acid-based therapy for autoimmune diabetes (TIDM): Leucine increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increase insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM via up regulation of its target gene, 12/February/2018,11.14 pm
Natural product-based therapy for diabetes (TIDM): Puerarin, isolated from Kudju or Puraria Montana, increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 12/February/2018,12.43 am
February 11, 2018
Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: A pharmaceutical mixture encompassing Pyridoxamine and Pantoprazole increases the expression of ERBB2/Her2 and promotes dedifferentiation of cardiomyocytes via down regulation of its target gene, 12/February/2018, 11.49 pm
February 12, 2018
Related posts
December 14, 2021
LncRNA-based regenerative cardiovascular therapy: Sirtuin 5 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 14/December/2021, 6.38 am
December 14, 2021
Molecular therapy for safeguarding your heart against cardiac dysfunction: MiR-488-5p-based therapy for cardiomyocyte proliferation and heart regeneration: MiR-488-5p decreases tumor suppressor Mir-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up-regulation of its target gene, 22/October/2021, 12.07 pm
November 1, 2021